targeting bcma for r/r myeloma
Published 3 years ago • 136 plays • Length 11:01Download video MP4
Download video MP3
Similar videos
-
2:31
integrating bcma-targeted agents in earlier lines of therapy for r/r multiple myeloma
-
3:28
the importance of bcma-targeting adcs and bispecific antibodies in r/r multiple myeloma
-
1:02
managing progression after bcma-targeted therapy in r/r multiple myeloma
-
1:52
first-in-human results of the anti-bcma antibody-drug conjugate hdp-101 in r/r myeloma
-
1:38
using bcma-targeting agents in earlier lines of treatment for multiple myeloma
-
49:35
mcrt webinar may 2020: round table audience q&a – session one faculty
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:57
what is the survival rate for multiple myeloma?
-
1:47
abnormal serum immunofixation patterns following bcma car-t in multiple myeloma
-
1:45
targetting bcma in myeloma
-
1:15
the current status and future of car-t therapy in r/r myeloma
-
3:30
sc vs. iv administration of a bcma-cd3 bispecific antibody for r/r myeloma
-
2:31
the value of bcma-targeting therapy in multiple myeloma: current applications and future outlooks
-
1:47
role of bcma-targeting adcs in the management of myeloma
-
1:16
the value of bcma-targeting agents in treating patients with penta-refractory multiple myeloma
-
1:29
sequencing bcma-targeted therapies in myeloma
-
5:00
meta-analysis: anti-bcma car-t in r/r multiple myeloma
-
1:42
first-in-human trial of an anti-bcma adc for r/r myeloma
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
1:02
bcma-specific car-t cells for r/r multiple myeloma